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Abstract
Background: Stepped wedge randomised trial designs involve sequential roll-out of an
intervention to participants (individuals or clusters) over a number of time periods. By the end of
the study, all participants will have received the intervention, although the order in which
participants receive the intervention is determined at random. The design is particularly relevant
where it is predicted that the intervention will do more good than harm (making a parallel design,
in which certain participants do not receive the intervention unethical) and/or where, for logistical,
practical or financial reasons, it is impossible to deliver the intervention simultaneously to all
participants. Stepped wedge designs offer a number of opportunities for data analysis, particularly
for modelling the effect of time on the effectiveness of an intervention. This paper presents a review
of 12 studies (or protocols) that use (or plan to use) a stepped wedge design. One aim of the review
is to highlight the potential for the stepped wedge design, given its infrequent use to date.
Methods: Comprehensive literature review of studies or protocols using a stepped wedge design.
Data were extracted from the studies in three categories for subsequent consideration: study
information (epidemiology, intervention, number of participants), reasons for using a stepped
wedge design and methods of data analysis.
Results: The 12 studies included in this review describe evaluations of a wide range of
interventions, across different diseases in different settings. However the stepped wedge design
appears to have found a niche for evaluating interventions in developing countries, specifically those
concerned with HIV. There were few consistent motivations for employing a stepped wedge design
or methods of data analysis across studies. The methodological descriptions of stepped wedge
studies, including methods of randomisation, sample size calculations and methods of analysis, are
not always complete.
Conclusion: While the stepped wedge design offers a number of opportunities for use in future
evaluations, a more consistent approach to reporting and data analysis is required.
Background
Randomised Controlled Trials (RCTs) are considered the
'Gold Standard' test of clinical effectiveness [1] and such
trials are increasingly being used in evaluations of non-
clinical interventions. There are many ways of classifying
RCTs, such as the extent of blinding, method of randomi-
sation (including whether interventions will be ran-
domised at individual or cluster level) and the inclusion
(or not) of a preference arm [2]. A further classification is
the way in which participants are exposed to the interven-
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paper provides a review of studies employing a particular
design, known as a 'stepped wedge'.
In a stepped wedge design, an intervention is rolled-out
sequentially to the trial participants (either as individuals
or clusters of individuals) over a number of time periods.
The order in which the different individuals or clusters
receive the intervention is determined at random and, by
the end of the random allocation, all individuals or
groups will have received the intervention. Stepped wedge
designs incorporate data collection at each point where a
new group (step) receives the intervention. An example of
the logistics of a stepped wedge trial design is shown in
Figure 1, which shows a stepped wedge design with five
steps. Data analysis to determine the overall effectiveness
of the intervention subsequently involves comparison of
the data points in the control section of the wedge with
those in the intervention section.
Cook and Campbell were possibly the first authors to con-
sider the potential for experimentally staged introduction in
a situation when an innovation cannot be delivered con-
currently to all units [3]. The first empirical example of
this design being employed is in the Gambia Hepatitis
Study, which was a long-term effectiveness study of Hep-
atitis B vaccination in the prevention of liver cancer and
chronic liver disease [4]. It is from this latter study that we
have taken the term 'stepped wedge'.
There are two key (non-exclusive) situations in which a
stepped wedge design is considered advantageous when
compared to a traditional parallel design. First, if there is
a prior belief that the intervention will do more good than
harm [5], rather than a prior belief of equipoise [6], it may
be unethical to withhold the intervention from a propor-
tion of the participants, or to withdraw the intervention as
would occur in a cross-over design. Second, there may be
logistical, practical or financial constraints that mean the
intervention can only be implemented in stages [3]. In
such circumstances, determining the order in which par-
ticipants receive the intervention at random is likely to be
both morally and politically acceptable and may also be
beneficial for trial recruitment [7]. An example of an inter-
vention where a stepped wedge design may be appropri-
ate in evaluation is a school-based anti-smoking
campaign that is delivered by one team of facilitators who
travel to each participating school in turn.
Example of a stepped wedge study designFigure 1
Example of a stepped wedge study design.
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is likely to lead to a longer trial duration than a traditional
parallel design, particularly where effectiveness is meas-
ured immediately after implementation. The design also
imposes some practical implementation challenges, such
as preventing contamination between intervention partic-
ipants and those waiting for the intervention and ensuring
that those assessing outcomes are blind to the partici-
pant's status as intervention or control to help guard
against information bias. Blinding assessors is particularly
important since it is almost impossible to blind partici-
pants or those delivering the intervention, since both will
be aware of the 'step' from control to intervention status.
As will be shown in this paper, a variety of approaches to
statistical analysis have been employed empirically, in
part due to the complex nature of the analysis itself.
The potential benefits of employing a stepped wedge
design can be illustrated by considering the £20 m evalu-
ation of the Sure Start programme in the UK [8]. The
Department for Education and Skills ruled out a cluster
trial where the deprived areas identified as in need of Sure
Start would be randomised to either receive the interven-
tion or act as controls, since to intervene in some areas but
not in others was judged unacceptable. The evaluation has
instead used a non-randomised control group, consisting
of 50 "Sure Start-to-be" communities, compared to the
260 Sure Start intervention communities. However the
local programmes, evaluated by Belskey et al. [9] were in
fact introduced in six waves between 1999 and 2003 [10].
This implementation strategy actually provided an excel-
lent opportunity for a stepped wedge study design, which
would have met both ethical and scientific imperatives.
Determining the order in which communities received the
intervention at random would have been demonstrably
impartial and hence a fair way to allocate resources. From
the scientific point of view, randomisation would elimi-
nate allocation bias and the stepped wedge deign would
have offered a further opportunity to measure possible
effects of time of intervention on the effectiveness of the
intervention. Since no pre-intervention measurements
were undertaken, it was also impossible to separate the
effects of the Sure Start programmes from any underlying
temporal changes within each community and these
effects could also have been investigated through the use
of a stepped wedge design.
In this paper, we provide a review of studies employing a
stepped wedge design. The review includes studies based
on both individual and cluster allocations and is not
restricted to RCTs. Indeed, we do not apply any methodo-
logical filters. The aim of the review is to determine the
extent to which the stepped wedge design has been
employed empirically and, for the available studies, to
examine the background epidemiology, why researchers
decided on a stepped wedge design and methods of data
analysis. The review is intended to be systematic and
includes trials from all fields. However we would be inter-
ested to hear about any further examples that our search
may have missed.
Methods
Search strategy
We searched the Current Controlled Trials Register, the
Cochrane Database, Medline, Cinahl, Embase, PsycInfo,
Web of Knowledge and Google Scholar for papers and
trial protocols using the following phrases: step wedge,
stepped wedge, experimentally staged introduction and
the nine possible combinations of incremental/phased/
staggered and recruitment/introduction/implementation.
The search was undertaken in October 2005 and repeated
in March 2006. In addition, we checked the citations of
the original Gambia Hepatitis Study and the references
and citations of other relevant papers. We included any
relevant papers in the English language that employed a
stepped wedge design (although as indicated by the
search terms the authors may have used an alternative
term to describe their trial design), but did not include
any date or subject restrictions. We exclude multiple base-
line designs, which are generally applied to analyse the
response of single subjects to an intervention and where
analysis is undertaken separately for each individual,
since exposure to the intervention is often delayed until a
stable baseline has been achieved rather than being deter-
mined randomly [11]. Given our focus on study design,
we exclude any follow-up papers presenting further results
and analysis of a study already included in the review.
Data extraction and analysis
Data were extracted from studies included in the review
onto a standard proforma (see Additional file 1) in three
main categories: basic information about the trial (includ-
ing epidemiology, intervention and trial size), reasons for
using a stepped wedge design and methods of data analy-
sis. Data were transposed from the proformas to a data-
base that was subsequently interrogated to elicit summary
information and key themes in each of the three catego-
ries across all of the studies.
Results and discussion
Yield
Figure 2 shows the results of our search which identified
only 12 papers or protocols (referred to as studies) in
which a stepped wedge design was described. The studies
included in the review described their study design as
either stepped wedge or phased introduction/implemen-
tation. We contacted the authors of the conference pro-
ceeding report identified by a citation check and a
protocol identified by the Controlled Trials Register but
were unable to obtain sufficient information about thesePage 3 of 9
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studies [12-14] are protocols describing trials that were
being designed or implemented rather than providing
results of the evaluation. Basic information about each of
the included studies is shown in Tables 1, 2, 3.
Epidemiology and study details
While the small sample makes generalisations difficult,
the stepped wedge design appears to be primarily used in
evaluating interventions in developing countries, with
HIV the most common disease addressed (Table 1). Table
2 identifies that a number of different interventions were
being evaluated, with vaccination, screening and educa-
Results of literature searchFig re 2
Results of literature search.
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Such interventions are likely to have an existing evidence
base, adding to intuitive beliefs that the intervention is
likely to do more good than harm. It is also possible that
the use of the stepped wedge design is increasing, with 9
(75%) of the studies published since 2002.
As shown in Table 2, three of the studies were randomised
(and thus stepped) at the level of the individual and we
suspect that Fairley et al. [15] also applied individual-level
randomisation, since this study is a precursor to another
similar study [16]. The remaining eight studies are cluster
trials, with houses, clinics, wards and districts receiving
the intervention in each time period. Of the cluster stud-
ies, three [14,17,18] are cohort designs (with the same
individuals in each cluster in the pre and post intervention
steps) and the remainder are repeated cross-section
designs (with different individuals in each cluster in the
pre and post intervention steps). It is only permissible to
include terminal end-points (such as death) in studies
with a repeated cross-sectional design: in individual/
cohort designs if a participant has died in the control
phase, it is impossible for them to die in the intervention
stage. Nevertheless, this axiom is violated in one of the
cohort designs [19] where incidence and mortality from
ruptured abdominal aortic aneurysms are used as end-
points. This problem is likely to introduce a "healthy sur-
vivor" bias [20].
Two of the cluster studies [12,18] did not indicate
whether stepping was randomised. In addition, it is not
clear whether the order in which Nutritional Rehabilita-
tion Units were allocated to the intervention was deter-
mined at random in the study reported by Ciliberto et al.
[21], although this is unlikely given that the paper sug-
gests that randomised assignment in which some clusters
would not receive the intervention was not possible due
to resource constraints and cultural beliefs. However, of
the remaining nine studies, only three [14,20,22] pro-
vided any detail on the method of randomisation
employed and none of these would have fulfilled all of
the requirements relating to randomisation (sequence
Table 2: Study interventions
Lead Author Date Nature of Intervention Level of 'stepping' Is 'stepping' randomised? Primary outcome measure
Gambia Hepatitis Study Group [4] 1987 Hepatitis B vaccination Vaccination team Yes Liver cancer rates/Vaccine efficacy
Cook [17] 1996 Educational programme Cohort Yes Health Behaviour Questionnaire 
measures
Wilmink [19] 1999 Screening programme Surgery and Individual Surgery – not stated; 
individual – yes
Incidence and mortality of RAAAs
Somerville [14] 2002 Improvements to housing Sets of houses Yes Respiratory Health Symptoms
Fairley [15] 2003 Education programme and 
individual plans
Not stated Yes Proportion of missed doses
Hughes [12] 2003 Provision of Nevirapine to 
pregnant HIV+ women
Pre-natal clinic Not stated Mother to child HIV transmission
Levy [16] 2004 Education programme and 
individual plans
Individual Yes Proportion of missed doses
Priestly [22] 2004 Critical care outreach teams Ward Yes – in pairs Rate of in-hospital deaths
Bailey [18] 2004 Provision of piped water to house 
yards
District Not stated Water quality
Grant [20] 2005 Screening and Isoniazid therapy Individual Yes TB episodes >90 days after clinic 
entry
Ciliberto [21] 2005 Home-based therapy with ready to 
use therapeutic food
Rehab unit Not stated Attainment WHZ score >-2/Death
Chaisson [13] 2005 Screening and treatment for TB Clinic Yes TB Incidence
Table 1: Study epidemiology
Lead Author Date Disease Country Setting
Gambia Hepatitis Study Group [4] 1987 Liver cancer Gambia Regions
Cook [17] 1996 Substance abuse USA Workplace
Wilmink [19] 1999 Ruptured abdominal aortic aneurysms UK GP surgeries
Somerville [14] 2002 Respiratory Health UK Houses in Watcombe
Fairley [15] 2003 HIV (Adherence to antiretroviral therapy) Australia Sexual health clinic
Hughes [12] 2003 HIV (Mother to child transmission) Zambia and Uganda Health clinics
Levy [16] 2004 HIV (Adherence to antiretroviral therapy) Australia Ambulatory care clinic in a tertiary hospital
Priestly [22] 2004 Critical care UK NHS hospital trust
Bailey [18] 2004 Water-borne diseases South Africa Households
Grant [20] 2005 TB in HIV+ men South Africa Company health centre
Ciliberto [21] 2005 Childhood malnutrition Malawi National rehabilitation units
Chaisson [13] 2005 TB in HIV+ men Brazil HIV clinicsPage 5 of 9
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detailed in the CONSORT statement or its extension for
cluster studies [23,24].
As noted above, it is almost impossible to blind partici-
pants or those involved in delivering the intervention
from being aware of whether a participant is currently in
the control or intervention section of the wedge. This
makes blinding of those assessing outcomes particularly
important in protecting against information biases, par-
ticularly where outcomes are subjective. None of the stud-
ies in the sample provided enough detail to determine
whether outcome assessments were blinded, with one
study [14] deciding not to blind assessors to help main-
tain response rates. The intervention in this study
involved improvements to housing, with health and envi-
ronmental assessments undertaken in participants' homes
so that participants would not have to travel to a 'neutral'
location.
The studies varied considerably in terms of number of
steps and number of participants (Table 3). It may be rel-
evant to question whether there is a minimum number of
steps required for the trial to be classed as a stepped
wedge. Three of the studies [12,14,17] include only two
steps. In two of these studies [14,17] participants are ran-
domised to two cohorts, with one cohort receiving the
intervention while the other cohort served as the control.
The control groups subsequently receive the intervention
and further evaluation of effectiveness was undertaken,
suggestive of the stepped wedge approach. The third study
[12] employs what the authors term a "combined paral-
lel/stepped wedge design", although only four out of the
eight clusters crossed-over from the control to the inter-
vention groups, with all of these clusters crossing-over at
the same time. The mean number of steps in the remain-
ing five cluster studies was 13 (range 4–29). Sample size
calculations are reported in just five studies
[4,12,13,21,22].
Motivations for employing a stepped wedge design
All of the studies bar one [15] identified one or more
motivations for employing a stepped wedge design,
although the level of detail regarding motivations varied.
Four studies [16,17,20,21] reported using a stepped
wedge design to prevent ethical objections arising from
withholding an intervention anticipated to be beneficial.
Practical difficulties with providing the intervention to
everyone simultaneously were mentioned in four studies,
due to insufficient resources in three [4,14,21] and logis-
tical difficulties in two [4,18]. The authors reported a
desire to use an RCT for evaluation in four studies
[4,14,17,22] and scientific reasons were given in five stud-
ies: allowing individuals/clusters to act as their own con-
Table 3: Study size
Lead Author Date Number of 'steps' Number of 
participants:
Time period between steps
Intervention Control
Gambia Hepatitis Study Group [4] 1987 17 61,065 63,512 10–12 weeks
Cook [17] 1996 2 371 Not stated
Wilmink [19] 1999 Individual – 13,147 29,713 person years 70,298 person years Not stated – total 6 years
Somerville [14] 2002 2 119 1 year
Fairley [15] 2003 43 43 Not stated – total 20 weeks
Hughes [12] 2003 2 Aim: 304 Aim: 304 7 months (4 intervention, 3 
wash-out)
Levy [16] 2004 Not stated (2 
randomisation 
periods)
68 Not stated – total 20 weeks
Priestly [22] 2004 8 2,903 4,547 4 weeks
Bailey [18] 2004 4 400 About 3 months
Grant [20] 2005 1,655 1,655 Not stated – total 26 months
Ciliberto [21] 2005 7 992 186 3 weeks
Chaisson [13] 2005 29 Not stated 1 month
Notes:
The number of individuals is based on recruitment to the trial, rather than completed follow-up numbers.
Where only one figure for the number of participants is given, each individual/household participant receives the intervention at some stage during 
the trial.
In the Wilmink study [19], individuals cross-over from control to intervention at various points, but contribute person-years of data to both 
sections of the wedge.
In the remaining four studies with both 'intervention' and 'control' participants [4, 12, 21, 22], the unit of randomisation is the clinic or ward and 
hence an individual visiting the clinic/ward while it is in the control section of the wedge will not receive the intervention. Individuals visiting the 
clinic/ward once it has crossed-over to intervention will then contribute data to the intervention section of the wedge.Page 6 of 9
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time [12,13,20,21].
Methods of data analysis
No two studies use the same methods of analysing data,
although most compare outcomes in the intervention and
control sections of the stepped wedge across the entire
data set. The primary method(s) of data analysis for each
study are shown in Table 4. These methods vary consider-
ably in terms of their complexity and there is insufficient
information to determine the appropriateness of each
method. Only two studies [13,14] propose a cost-effec-
tiveness analysis. The two studies that apply step-by-step
analysis [4,13] provide a separate analysis for each step in
the trial, in order to separate out underlying time trends.
Of the remaining studies that reported using a stepped
wedge design to control for underlying time trends, Grant
et al. [20] apply a Poisson random effects model to con-
trol for disease progression and Ciliberto et al. [21] use
linear and logistic models to consider the effect of month
(as a seasonal effect), although the results are not
reported. The Hughes et al. [12] protocol includes time as
a component in the model, but the analytical approach to
be taken is not clear. Cook et al. [17] and Priestly et al.
[22] also consider the impact of time on effectiveness. The
latter uses matched pairs of wards to control for inter-tem-
poral changes, randomising one ward in each pair to early
intervention and one to late intervention. Analysis is then
undertaken using a sub-set of three 4-week time periods
for each ward pair, comparing the outcomes in interven-
tion and control wards across the same 12-week period.
Four of the studies [4,12,19,21] included long term fol-
low-up beyond the period in which stepping took place,
since the outcomes to be assessed may occur at a point fol-
lowing the final step (i.e. there is a lag between interven-
tion and outcome).
Conclusion
Our review has identified a number of evaluations where
a stepped wedge design was clearly appropriate and where
the design can provide sound evidence to guide future
practice. However not all of the studies included here
would fulfil the methodological requirements for a con-
trolled trial and hence we propose that if a stepped wedge
design is to be applied, authors should register their trial
on the Controlled Clinical Trials Register and follow
appropriate reporting guidelines, such as the CONSORT
statement or its equivalent for cluster trials [23,24]. A par-
ticular concern is with the lack of blinding of those assess-
ing subjective outcomes. This is important given the
difficulties associated with blinding participants and
those delivering the intervention from their status as inter-
vention or control, since it will nearly always be evident to
Table 4: Methods of analysis
Lead Author Date Primary outcome measure Method(s) of Analysis
Gambia Hepatitis Study Group [4] 1987 Liver cancer rates/Vaccine efficacy Comparisons of incidence rates on 
a step by step basis to identify 
vaccine efficacy
Cook [17] 1996 Health Behaviour Questionnaire 
measures
Comparison of group means and 
group by time, gender and 
education interactions (F-test)
Wilmink [19] 1999 Incidence and mortality of RAAAs Poisson likelihood distribution for 
incidence rates in person years and 
maximum likelihood rate ratios
Somerville [14] 2002 Respiratory Health Symptoms Not stated (description of 
intervention only)
Fairley [15] 2003 Proportion of missed doses Unpaired t-test of means
Hughes [12] 2003 Mother to child HIV transmission Not stated (protocol only)
Levy [16] 2004 Proportion of missed doses Wilcoxon rank-sum test
Priestly [22] 2004 Rate of in-hospital deaths Logistic regression Cox 
proportional hazard models 
(length of stay)
Bailey [18] 2004 Water quality Summary statistics only Time 
series analysis for diarrhoea rates
Grant [20] 2005 TB episodes >90 days after clinic 
entry
Poisson random effects model
Ciliberto [21] 2005 Attainment WHZ score >-2/Death 95% CI for differences between 
groups Linear and logistic 
regression for effects of covariates
Chaisson [13] 2005 TB Incidence Step by step analysis of incidence 
Conditional logistic regression 
Cost-effectiveness analysisPage 7 of 9
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occurs.
The heterogeneity of analytical methods applied in the
studies suggests that a formal model considering the
effects of time would help others planning a stepped
wedge trial and we will present our exposition of such a
model in a subsequent paper. A recent paper by Hussey
and Hughes [25] also provides detail regarding the analy-
sis of stepped wedge designs. Two particular statistical
challenges are controlling for inter-temporal changes in
outcome variables and accounting for repeated measures
on the same individuals over the duration of the trial.
The opportunities arising from modelling the effects of
time can be illustrated by considering the stepped wedge
design as a multiple arm parallel design, in which the
research aims not only to assess intervention effects, but
also to determine whether time of intervention (at the
extremes intervening early as opposed to intervening late)
impacts the effectiveness of the intervention. Such time
effects can also include seasonal variations and disease
progression: the latter may be particularly relevant when
evaluating interventions targeting treatments for HIV.
Although a traditional parallel trial design can be used to
examine general secular trends it cannot explore the par-
ticular relationship between time of intervention and
effectiveness.
One limitation of our review is the possibility that our
search strategy did not identify all of the studies that have
employed a stepped wedge design. In particular, we may
have missed 'delayed intervention' studies with two steps,
in which the delayed group receive the intervention after
the outcomes from initial intervention group have been
evaluated, but where the outcomes of the delayed group
are also evaluated. We have included three studies of this
nature in this review [12,14,17] although it is questiona-
ble whether studies with only two steps should be consid-
ered as stepped wedge designs. One reason for this is the
limitations for generalisation, particularly with respect to
the impact of time on effectiveness.
Considering the scientific advantages of the stepped
wedge design, it has rarely been used in practice and hence
we advocate the design for evaluating a wide range of
interventions, although we are not the first to do so [26-
28]. In terms of interventions likely to do more good than
harm, a stepped wedge design may be particularly benefi-
cial in evaluating interventions being implemented in a
new setting, where evidence for their effectiveness in the
original setting is available, or for patient safety interven-
tions that have undergone careful pre-implementation
evaluation to rule out any collateral damage. The stepped
wedge design may also be appropriate for cost-effective-
ness analyses of interventions that have already been
shown to be effective. However, the stepped wedge design
requires a longer trial duration than parallel designs and
also presents a number of challenges, including both prac-
tical and statistical complexity. Hence careful planning
and monitoring are required in order to ensure that a
robust evaluation is undertaken.
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